Proapoptotic Strategy in Cancer Gene Therapy
作者： David H. Holman , Marc L. Hyer , Ahmed El-Zawahry , Gina M. Keller , James S. Norris
DOI: 10.1007/978-1-59259-785-7_18
关键词:
摘要: With the recent availability of human genome sequence and development bioinformatic tools to analyze these results, promise gene therapy is broad. Further, our understanding causes cancer are rapidly expanding with developing genomics, proteomics, metabolomics, which when analyzed continually bioinformatics will provide insight into myriad cellular signaling pathways that become disturbed in cancer. Thus, there now an abundance genes available for introduction correct better-understood growth aberrations.
springer.com
sci-hub.st 参考文章(163)
Nielsen Ll, Armstrong L, Maneval D, Dell J, Catino Jj, Maxwell E, Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Therapy. ,vol. 4, pp. 129- 138 ,(1997)
Seiji Kondo, Barbara P Barna, Yasuko Kondo, Yoshikazu Tanaka, Graham Casey, Jinbo Liu, Tatsuo Morimura, Rami Kaakaji, John W Peterson, Brian Werbel, Gene H Barnett, None, WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene. ,vol. 13, pp. 1279- 1285 ,(1996)
You-Jun Li, Khe Hoang-Xuan, Jean-Yves Delattre, Michel Poisson, Gilles Thomas, R. Hamelin, None, Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene. ,vol. 11, pp. 597- 600 ,(1995)
Wu Y, Zheng X, Zhu X, Bai J, Retroviral vector containing human p16 gene and its inhibitory effect on Bcap-37 breast cancer cells. Chinese Medical Journal. ,vol. 114, pp. 497- 501 ,(2001)
Claudia Friesen, Ingrid Herr, Peter H. Krammer, Klaus-Michael Debatin, Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine. ,vol. 2, pp. 574- 577 ,(1996) , 10.1038/NM0596-574
M H Lee, I Reynisdottir, J Massague, Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Development. ,vol. 9, pp. 639- 649 ,(1995) , 10.1101/GAD.9.6.639
Steven J Robles, Guy R Adami, Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. ,vol. 16, pp. 1113- 1123 ,(1998) , 10.1038/SJ.ONC.1201862
R. Day, B. Johnson, M. Skolnick, A Kamb, N. Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S. Tavtigian, E Stockert, A cell cycle regulator potentially involved in genesis of many tumor types Science. ,vol. 264, pp. 436- 440 ,(1994) , 10.1126/SCIENCE.8153634
H. Lincet, L. Poulain, J.S. Remy, E. Deslandes, F. Duigou, P. Gauduchon, C. Staedel, The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Letters. ,vol. 161, pp. 17- 26 ,(2000) , 10.1016/S0304-3835(00)00586-3
Benjamin B. Ambar, Karl Frei, Ursula Malipiero, Adrian E. Morelli, Maria G. Castro, Pedro R. Lowenstein, Adriano Fontana, Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Human Gene Therapy. ,vol. 10, pp. 1641- 1648 ,(1999) , 10.1089/10430349950017644